These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8415867)

  • 21. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano M; Calapai G; Campo GM; Miceli A; Caputi AP
    Eur J Pharmacol; 1993 Jun; 237(2-3):223-30. PubMed ID: 8396037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
    Tsao PS; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel thromboxane A2 receptor antagonist KW-3635 reduces infarct size in a canine model of coronary occlusion and reperfusion.
    Higo K; Sano J; Karasawa A; Kubo K
    Arch Int Pharmacodyn Ther; 1993; 323():32-49. PubMed ID: 8250642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.
    Rolin S; Petein M; Tchana-Sato V; Dogne JM; Benoit P; Lambermont B; Ghuysen A; Kolh P; Masereel B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):59-65. PubMed ID: 12721335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A.
    Wargovich TJ; Mehta J; Nichols WW; Ward MB; Lawson D; Franzini D; Conti CR
    Am Heart J; 1987 Nov; 114(5):1078-85. PubMed ID: 2960223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):1-9. PubMed ID: 26531833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
    Smith EF; Egan JW; Griswold DE
    Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R.
    Liu P; Xu B; Cavalieri TA; Hock CE
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2719-27. PubMed ID: 15358609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart.
    Wu X; Zhang B; Fan R; Zhao L; Wang Y; Zhang S; Kaye AD; Huang L; Pei J
    Cytokine; 2011 Nov; 56(2):503-7. PubMed ID: 21843951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
    Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
    Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
    Altavilla D; Canale P; Squadrito F; Sardella A; Ammendolia L; Urna G; Ioculano M; Squadrito G; Caputi AP
    Pharmacol Res; 1994; 30(2):137-51. PubMed ID: 7816742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
    Kolh P; Rolin S; Tchana-Sato V; Pétein M; Ghuysen A; Lambermont B; Hanson J; Magis D; Segers P; Masereel B; D'Orio V; Dogne JM
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):53-73. PubMed ID: 16516810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
    Leor J; Varda-Bloom N; Hasdai D; Ovadia Z; Battler A
    Angiology; 1994 Aug; 45(8):717-24. PubMed ID: 8048781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of infarct size and infiltration of polymorphonuclear leukocytes by a thromboxane synthetase inhibitor. Studies in a rabbit ischemic heart model.
    Ito T; Asai F; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1990 Jan; 40(1):23-7. PubMed ID: 1692704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of myocardial infarct size in rat by IRFI-048, a selective analogue of vitamin E.
    Campo GM; Squadrito F; Ioculano M; Altavilla D; Calapai G; Zingarelli B; Scuri R; Caputi AP
    Free Radic Biol Med; 1994 Apr; 16(4):427-35. PubMed ID: 8005527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
    Lefer AM; Mentley R; Sun JZ
    Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
    Hock CE; Phillips GR; Lefer AM
    Prostaglandins Leukot Med; 1985 Mar; 17(3):339-46. PubMed ID: 3857643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury.
    Ioculano M; Altavilla D; Squadrito F; Canale P; Squadrito G; Saitta A; Campo GM; Caputi AP
    Pharmacol Res; 1995 May; 31(5):281-8. PubMed ID: 7479525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.